Report Detail
Global Cardiac Resynchronization Therapy Defibrillator Market Insights, Forecast to 2025
- RnM3518546 |
- 12 June, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
A CRT-D is a special device for heart failure patients who are also at high risk for sudden cardiac death. While functioning like a normal pacemaker to treat slow heart rhythms, a CRT-D device also delivers small electrical impulses to the left and right ventricles to help them contract at the same time. This will help your heart pump more efficiently. A CRT-D device can also treat dangerously fast heart rhythms (arrhythmias) that can lead to sudden cardiac arrest. If the device senses heartbeats that are dangerously fast, it delivers a shock to the heart. This shock (defibrillation) stops the abnormal rhythm. Without this life-saving therapy, the dangerously rapid rhythm could lead to death in just minutes.
Factors such as rising incidences of cardiac disorders, advanced surgical procedures such as minimally invasive (MI) surgeries, patient awareness, and increasing healthcare spending are the primary growth drivers for the CRT-D market. Several clinical research studies indicate that when compared to CRT-P devices, the CRT-D devices can reduce re-admissions to the hospital for patients with heart failure, which is leading to their increased implementation in several cardiac procedures. Also, CRT-D devices lower the risk of sudden cardiac death (SCD) and improve the left ventricular function.
The Americas will be the largest revenue contributing region in the market by 2020 and is expected to occupy more than 55% of the total market share. The rising incidences of cardiac disorders and growing awareness about cardiac diseases are the primary growth drivers for this region. Factors such as growing number of implant centers, technological advancements and easy availability of reimbursements will propel the sales of CRT-D devices in the region.
The global Cardiac Resynchronization Therapy Defibrillator market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cardiac Resynchronization Therapy Defibrillator market based on company, product type, end user and key regions.
This report studies the global market size of Cardiac Resynchronization Therapy Defibrillator in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cardiac Resynchronization Therapy Defibrillator in these regions.
This research report categorizes the global Cardiac Resynchronization Therapy Defibrillator market by top players/brands, region, type and end user. This report also studies the global Cardiac Resynchronization Therapy Defibrillator market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Boston Scientific
Medtronic
St. Jude Medical
Biotronik
Spectranetics
Market size by Product
G158
G156
Others
Market size by End User
Hospital
Clinic
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Cardiac Resynchronization Therapy Defibrillator market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Cardiac Resynchronization Therapy Defibrillator market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Cardiac Resynchronization Therapy Defibrillator companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Cardiac Resynchronization Therapy Defibrillator submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Cardiac Resynchronization Therapy Defibrillator are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cardiac Resynchronization Therapy Defibrillator market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Cardiac Resynchronization Therapy Defibrillator Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Cardiac Resynchronization Therapy Defibrillator Market Size Growth Rate by Product
- 1.4.2 G158
- 1.4.3 G156
- 1.4.4 Others
- 1.5 Market by End User
- 1.5.1 Global Cardiac Resynchronization Therapy Defibrillator Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cardiac Resynchronization Therapy Defibrillator Market Size
- 2.1.1 Global Cardiac Resynchronization Therapy Defibrillator Revenue 2014-2025
- 2.1.2 Global Cardiac Resynchronization Therapy Defibrillator Sales 2014-2025
- 2.2 Cardiac Resynchronization Therapy Defibrillator Growth Rate by Regions
- 2.2.1 Global Cardiac Resynchronization Therapy Defibrillator Sales by Regions
- 2.2.2 Global Cardiac Resynchronization Therapy Defibrillator Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Cardiac Resynchronization Therapy Defibrillator Sales by Manufacturers
- 3.1.1 Cardiac Resynchronization Therapy Defibrillator Sales by Manufacturers
- 3.1.2 Cardiac Resynchronization Therapy Defibrillator Sales Market Share by Manufacturers
- 3.1.3 Global Cardiac Resynchronization Therapy Defibrillator Market Concentration Ratio (CR5 and HHI)
- 3.2 Cardiac Resynchronization Therapy Defibrillator Revenue by Manufacturers
- 3.2.1 Cardiac Resynchronization Therapy Defibrillator Revenue by Manufacturers (2014-2019)
- 3.2.2 Cardiac Resynchronization Therapy Defibrillator Revenue Share by Manufacturers (2014-2019)
- 3.3 Cardiac Resynchronization Therapy Defibrillator Price by Manufacturers
- 3.4 Cardiac Resynchronization Therapy Defibrillator Manufacturing Base Distribution, Product Types
- 3.4.1 Cardiac Resynchronization Therapy Defibrillator Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cardiac Resynchronization Therapy Defibrillator Product Type
- 3.4.3 Date of International Manufacturers Enter into Cardiac Resynchronization Therapy Defibrillator Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Cardiac Resynchronization Therapy Defibrillator Sales by Product
- 4.2 Global Cardiac Resynchronization Therapy Defibrillator Revenue by Product
- 4.3 Cardiac Resynchronization Therapy Defibrillator Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Cardiac Resynchronization Therapy Defibrillator Breakdown Data by End User
6 North America
- 6.1 North America Cardiac Resynchronization Therapy Defibrillator by Countries
- 6.1.1 North America Cardiac Resynchronization Therapy Defibrillator Sales by Countries
- 6.1.2 North America Cardiac Resynchronization Therapy Defibrillator Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Cardiac Resynchronization Therapy Defibrillator by Product
- 6.3 North America Cardiac Resynchronization Therapy Defibrillator by End User
7 Europe
- 7.1 Europe Cardiac Resynchronization Therapy Defibrillator by Countries
- 7.1.1 Europe Cardiac Resynchronization Therapy Defibrillator Sales by Countries
- 7.1.2 Europe Cardiac Resynchronization Therapy Defibrillator Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cardiac Resynchronization Therapy Defibrillator by Product
- 7.3 Europe Cardiac Resynchronization Therapy Defibrillator by End User
8 Asia Pacific
- 8.1 Asia Pacific Cardiac Resynchronization Therapy Defibrillator by Countries
- 8.1.1 Asia Pacific Cardiac Resynchronization Therapy Defibrillator Sales by Countries
- 8.1.2 Asia Pacific Cardiac Resynchronization Therapy Defibrillator Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Cardiac Resynchronization Therapy Defibrillator by Product
- 8.3 Asia Pacific Cardiac Resynchronization Therapy Defibrillator by End User
9 Central & South America
- 9.1 Central & South America Cardiac Resynchronization Therapy Defibrillator by Countries
- 9.1.1 Central & South America Cardiac Resynchronization Therapy Defibrillator Sales by Countries
- 9.1.2 Central & South America Cardiac Resynchronization Therapy Defibrillator Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Cardiac Resynchronization Therapy Defibrillator by Product
- 9.3 Central & South America Cardiac Resynchronization Therapy Defibrillator by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Cardiac Resynchronization Therapy Defibrillator by Countries
- 10.1.1 Middle East and Africa Cardiac Resynchronization Therapy Defibrillator Sales by Countries
- 10.1.2 Middle East and Africa Cardiac Resynchronization Therapy Defibrillator Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Cardiac Resynchronization Therapy Defibrillator by Product
- 10.3 Middle East and Africa Cardiac Resynchronization Therapy Defibrillator by End User
11 Company Profiles
- 11.1 Boston Scientific
- 11.1.1 Boston Scientific Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Boston Scientific Cardiac Resynchronization Therapy Defibrillator Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Boston Scientific Cardiac Resynchronization Therapy Defibrillator Products Offered
- 11.1.5 Boston Scientific Recent Development
- 11.2 Medtronic
- 11.2.1 Medtronic Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Medtronic Cardiac Resynchronization Therapy Defibrillator Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Medtronic Cardiac Resynchronization Therapy Defibrillator Products Offered
- 11.2.5 Medtronic Recent Development
- 11.3 St. Jude Medical
- 11.3.1 St. Jude Medical Company Details
- 11.3.2 Company Business Overview
- 11.3.3 St. Jude Medical Cardiac Resynchronization Therapy Defibrillator Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 St. Jude Medical Cardiac Resynchronization Therapy Defibrillator Products Offered
- 11.3.5 St. Jude Medical Recent Development
- 11.4 Biotronik
- 11.4.1 Biotronik Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Biotronik Cardiac Resynchronization Therapy Defibrillator Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Biotronik Cardiac Resynchronization Therapy Defibrillator Products Offered
- 11.4.5 Biotronik Recent Development
- 11.5 Spectranetics
- 11.5.1 Spectranetics Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Spectranetics Cardiac Resynchronization Therapy Defibrillator Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Spectranetics Cardiac Resynchronization Therapy Defibrillator Products Offered
- 11.5.5 Spectranetics Recent Development
12 Future Forecast
- 12.1 Cardiac Resynchronization Therapy Defibrillator Market Forecast by Regions
- 12.1.1 Global Cardiac Resynchronization Therapy Defibrillator Sales Forecast by Regions 2019-2025
- 12.1.2 Global Cardiac Resynchronization Therapy Defibrillator Revenue Forecast by Regions 2019-2025
- 12.2 Cardiac Resynchronization Therapy Defibrillator Market Forecast by Product
- 12.2.1 Global Cardiac Resynchronization Therapy Defibrillator Sales Forecast by Product 2019-2025
- 12.2.2 Global Cardiac Resynchronization Therapy Defibrillator Revenue Forecast by Product 2019-2025
- 12.3 Cardiac Resynchronization Therapy Defibrillator Market Forecast by End User
- 12.4 North America Cardiac Resynchronization Therapy Defibrillator Forecast
- 12.5 Europe Cardiac Resynchronization Therapy Defibrillator Forecast
- 12.6 Asia Pacific Cardiac Resynchronization Therapy Defibrillator Forecast
- 12.7 Central & South America Cardiac Resynchronization Therapy Defibrillator Forecast
- 12.8 Middle East and Africa Cardiac Resynchronization Therapy Defibrillator Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cardiac Resynchronization Therapy Defibrillator Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cardiac Resynchronization Therapy Defibrillator . Industry analysis & Market Report on Cardiac Resynchronization Therapy Defibrillator is a syndicated market report, published as Global Cardiac Resynchronization Therapy Defibrillator Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cardiac Resynchronization Therapy Defibrillator market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
